|
cardiac tamponade
|
DOID_115 |
|
|
prokaryotic metabolite
|
CHEBI_75787 |
|
|
lens disease
|
DOID_110 |
|
|
eye disease
|
DOID_5614 |
|
|
EC 1.14.13.78 (ent-kaurene oxidase) inhibitor
|
CHEBI_86430 |
|
|
EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor
|
CHEBI_76741 |
|
|
exposure keratitis
|
DOID_9461 |
|
|
keratoconjunctivitis
|
DOID_9368 |
|
|
uterine corpus cancer
|
DOID_9460 |
|
|
HIV-1 integrase inhibitor
|
CHEBI_67268 |
|
|
EC 2.7.* (P-containing group transferase) inhibitor
|
CHEBI_76668 |
|
|
anti-HIV-1 agent
|
CHEBI_64947 |
|
|
EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitor
|
CHEBI_67267 |
|
|
fatty liver disease
|
DOID_9452 |
|
|
intestinal infectious disease
|
DOID_100 |
|
|
disease by infectious agent
|
DOID_0050117 |
|
|
ischemic bone disease
|
DOID_0080008 |
|
|
lysosomal storage disease
|
DOID_3211 |
|
|
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor
|
CHEBI_73136 |
|
|
EC 2.7.11.12 (cGMP-dependent protein kinase) inhibitor
|
CHEBI_85113 |
|
